Introduction:

Preeclampsia and hypertensive disorders of pregnancy are a leading cause of maternal morbidity and mortality in the United States occurring in 12-22% of pregnancies. They are also responsible for approximately 17% of the maternal mortality in the United States. In addition, these disorders are also one of the leading contributors for premature birth which can then lead to significant neonatal morbidity and mortality as well. Screening and early recognition and treatment may prevent progression of the disease and improved outcomes for both the mother and the infant. Facilities are encouraged to adopt tools for screening and protocols for treatment of preeclampsia and hypertensive disorders.

 

References:



  • Improving Health Care Response to Preeclampsia: A California Quality Improvement Tool.  Errata May 13, 2014
  • Council on Patient Safety in Women’s Health Care Patient Safety Bundles and Tools

THA OB Contact

Jackie Moreland
Clinical Quality Improvement Specialist
615.401.7439
jmoreland@tha.com

Chris Clarke
Senior VP for Clinical Services
615.401.7437
cclarke@tha.com

Support

TCPS Programs are supported through funding from: